Novavax, Inc.

NASDAQ: NVAX
$7.72
-$0.22 (-2.8%)
Closing price February 21, 2020

Biotech Stocks Seeing the Biggest Boost From Coronavirus Outbreak

The story that has dominated this past week is that China is facing an outbreak of the coronavirus, and more countries around the world are seeing cases pop up. Global ...
Read Full Story »

Coronavirus Infections Climb Hand in Hand With These Biotech Stocks

China is facing an outbreak of the coronavirus, and more countries around the world are seeing cases pop up. Global infections of nearly 8,000 people have been reported, but only ...
Read Full Story »

12 Stocks Surging That Could Help Treat or Fight Coronavirus

Monday morning brought a huge sell-off in the market as more and more people are concerned about the growing impact of this new coronavirus. So far, over 2,800 cases and ...
Read Full Story »

As Coronavirus Spreads, Sensitive China, US, Global Economies Face Great Risks

The current coronavirus outbreak that originated in Wuhan in the Hubei province of China has become even more deadly and less contained. To add on more fears, there are now ...
Read Full Story »

Beyond Rising Deaths, Wuhan Coronavirus Already Hits China, US, Global Economies

The most recent coronavirus outbreak that originated in Wuhan in the Hubei province of China has become more deadly and is much less contained than global health officials would have ...
Read Full Story »

This Biotech Could Make a Big Splash With the Coronavirus Scare

The newest coronavirus out of China has resulted in a rising interest in biotechs that may be able to produce a vaccine or treatment with a short turnaround. We’ve seen ...
Read Full Story »

China’s Coronavirus Could Prompt Buying Frenzy in These Biotech Stocks

China is facing an outbreak of the coronavirus, which may have spread to a few other countries in East Asia. Although less than 300 infections have been reported, there are ...
Read Full Story »

Does FDA Decision Mean a Bright Future for This Flu Vaccine?

Novavax Inc. (NASDAQ: NVAX) shares jumped on Wednesday after the U.S. Food and Drug Administration (FDA) granted a Fast Track Designation for NanoFlu, its recombinant quadrivalent seasonal influenza vaccine candidate, ...
Read Full Story »

Thursday’s Top 4 Biotech Movers

Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff. Although the sector is feeling the pinch from the ...
Read Full Story »

The 6 Most Shorted Nasdaq Stocks

After the strong start to the year, the momentum in the big U.S. stock indexes began to slow late in February. Trade concerns and fears of inflation another recession lingered, ...
Read Full Story »

The 6 Most Shorted Nasdaq Stocks

As February began, the federal government shutdown was over and the January employment report was stronger than expected, but ongoing concerns about trade and fears of a recession lingered. It ...
Read Full Story »

The 6 Most Shorted Nasdaq Stocks

After a rough fourth quarter, with a particularly brutal December, things seemed to be looking up for stock investors in the new year, even with the bull market nearing 10 ...
Read Full Story »

The 6 Most Shorted Nasdaq Stocks

After one of the most brutal Decembers for stock investors in many years, we turned the calendar page on a new year. While the volatility did not go away, the ...
Read Full Story »

The 5 Most Shorted Nasdaq Stocks

December turned out to be one of the most brutal for stock investors in many years. That should have been good news for short sellers, depending on how they had ...
Read Full Story »

How Novavax Is Cashing In for Flu Season

Novavax Inc. (NASDAQ: NVAX) shares jumped early on Friday after the company reported that its midstage flu vaccine had some positive results. Essentially, the firm announced topline results of its ...
Read Full Story »